Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 220

1.

Blood eosinophil count and airway epithelial transcriptome relationships in COPD versus asthma.

George L, Taylor AR, Esteve-Codina A, Soler Artigas M, Thun GA, Bates S, Pavlidis S, Wagers S, Boland A, Prasse A, Boschetto P, Parr DG, Nowinski A, Barta I, Hohlfeld J, Greulich T, van den Berge M, Hiemstra PS, Timens W, Hinks T, Wenzel S, Siddiqui S, Richardson M, Venge P, Heath S, Gut I, Tobin MD, Edwards L, Riley JH, Djukanovic R, Auffray C, De-Meulder B, Erik-Dahlen S, Adcock IM, Chung KF, Ziegler-Heitbrock L, Sterk PJ, Singh D, Brightling CE; U-BIOPRED and the EvA study teams.

Allergy. 2019 Sep 10. doi: 10.1111/all.14016. [Epub ahead of print]

PMID:
31506971
2.

Rhinovirus-16 induced temporal interferon responses in nasal epithelium links with viral clearance and symptoms.

Ravi A, Chang M, van de Pol M, Yang S, Aliprantis A, Thornton B, Carayannopoulos LN, Bautmans A, Robberechts M, De Lepeleire I, Singh D, Hohlfeld JM, Sterk PJ, Krug N, Lutter R; U-BIOPRED Study Group.

Clin Exp Allergy. 2019 Aug 10. doi: 10.1111/cea.13481. [Epub ahead of print]

PMID:
31400236
3.

Left heart function in COPD : Impact of lung deflation.

Struß N, Bauersachs J, Welte T, Hohlfeld JM.

Herz. 2019 Sep;44(6):477-482. doi: 10.1007/s00059-019-4816-5.

PMID:
31187193
4.

Randomized immunotherapy trial in dual-allergic patients using "active allergen placebo" as control.

Wagenmann M, Worm M, Akboga Y, Karjalainen M, Hohlfeld JM.

Allergy. 2019 Aug;74(8):1480-1489. doi: 10.1111/all.13842. Epub 2019 May 28.

5.

Ultrafine particles and ozone perturb norepinephrine clearance rather than centrally generated sympathetic activity in humans.

Heusser K, Tank J, Holz O, May M, Brinkmann J, Engeli S, Diedrich A, Framke T, Koch A, Großhennig A, Jan Danser AH, Sweep FCGJ, Schindler C, Schwarz K, Krug N, Jordan J, Hohlfeld JM.

Sci Rep. 2019 Mar 6;9(1):3641. doi: 10.1038/s41598-019-40343-w.

6.

Activation of group 2 innate lymphoid cells after allergen challenge in asthmatic patients.

Winkler C, Hochdörfer T, Israelsson E, Hasselberg A, Cavallin A, Thörn K, Muthas D, Shojaee S, Lüer K, Müller M, Mjösberg J, Vaarala O, Hohlfeld J, Pardali K.

J Allergy Clin Immunol. 2019 Jul;144(1):61-69.e7. doi: 10.1016/j.jaci.2019.01.027. Epub 2019 Feb 4.

PMID:
30731124
7.

Rating sputum cell quality in clinical trials for asthma and COPD treatment.

Pedersen F, Zissler UM, Watz H, Rabe KF, Hohlfeld JM, Holz O.

Int J Chron Obstruct Pulmon Dis. 2019 Jan 8;14:195-198. doi: 10.2147/COPD.S188033. eCollection 2019. No abstract available.

8.

Effect of Indacaterol/Glycopyrronium on Pulmonary Perfusion and Ventilation in Hyperinflated Patients with Chronic Obstructive Pulmonary Disease (CLAIM). A Double-Blind, Randomized, Crossover Trial.

Vogel-Claussen J, Schönfeld CO, Kaireit TF, Voskrebenzev A, Czerner CP, Renne J, Tillmann HC, Berschneider K, Hiltl S, Bauersachs J, Welte T, Hohlfeld JM.

Am J Respir Crit Care Med. 2019 May 1;199(9):1086-1096. doi: 10.1164/rccm.201805-0995OC.

PMID:
30641027
9.

Repeatability of Regional Lung Ventilation Quantification Using Fluorinated (19F) Gas Magnetic Resonance Imaging.

Gutberlet M, Kaireit TF, Voskrebenzev A, Kern AL, Obert A, Wacker F, Hohlfeld JM, Vogel-Claussen J.

Acad Radiol. 2019 Mar;26(3):395-403. doi: 10.1016/j.acra.2018.10.021. Epub 2018 Nov 22.

PMID:
30472224
10.

Mapping of regional lung microstructural parameters using hyperpolarized 129 Xe dissolved-phase MRI in healthy volunteers and patients with chronic obstructive pulmonary disease.

Kern AL, Gutberlet M, Voskrebenzev A, Klimeš F, Rotärmel A, Wacker F, Hohlfeld JM, Vogel-Claussen J.

Magn Reson Med. 2019 Apr;81(4):2360-2373. doi: 10.1002/mrm.27559. Epub 2018 Oct 26.

PMID:
30362620
11.

Isolated aggregates of lymphoid cells in the inner bronchial wall in asthma patients.

Tschernig T, Pabst R, Prenzler F, Rittinghausen S, Braun A, Hohlfeld JM.

Cell Tissue Res. 2018 Nov;374(2):423-425. doi: 10.1007/s00441-018-2936-5. Epub 2018 Oct 5.

PMID:
30291417
12.

Regional investigation of lung function and microstructure parameters by localized 129 Xe chemical shift saturation recovery and dissolved-phase imaging: A reproducibility study.

Kern AL, Gutberlet M, Qing K, Voskrebenzev A, Klimeš F, Kaireit TF, Czerner C, Biller H, Wacker F, Ruppert K, Hohlfeld JM, Vogel-Claussen J.

Magn Reson Med. 2019 Jan;81(1):13-24. doi: 10.1002/mrm.27407. Epub 2018 Sep 9.

PMID:
30198113
13.

BAL Cell Gene Expression Is Indicative of Outcome and Airway Basal Cell Involvement in Idiopathic Pulmonary Fibrosis.

Prasse A, Binder H, Schupp JC, Kayser G, Bargagli E, Jaeger B, Hess M, Rittinghausen S, Vuga L, Lynn H, Violette S, Jung B, Quast K, Vanaudenaerde B, Xu Y, Hohlfeld JM, Krug N, Herazo-Maya JD, Rottoli P, Wuyts WA, Kaminski N.

Am J Respir Crit Care Med. 2019 Mar 1;199(5):622-630. doi: 10.1164/rccm.201712-2551OC.

PMID:
30141961
14.

Epithelial IL-6 trans-signaling defines a new asthma phenotype with increased airway inflammation.

Jevnikar Z, Östling J, Ax E, Calvén J, Thörn K, Israelsson E, Öberg L, Singhania A, Lau LCK, Wilson SJ, Ward JA, Chauhan A, Sousa AR, De Meulder B, Loza MJ, Baribaud F, Sterk PJ, Chung KF, Sun K, Guo Y, Adcock IM, Payne D, Dahlen B, Chanez P, Shaw DE, Krug N, Hohlfeld JM, Sandström T, Djukanovic R, James A, Hinks TSC, Howarth PH, Vaarala O, van Geest M, Olsson H; Unbiased Biomarkers in Prediction of Respiratory Disease Outcomes study group.

J Allergy Clin Immunol. 2019 Feb;143(2):577-590. doi: 10.1016/j.jaci.2018.05.026. Epub 2018 Jun 11.

15.

Assessment of the Power Required for Optimal Use of Current Inhalation Devices.

Pohlmann G, Hohlfeld JM, Haidl P, Pankalla J, Cloes RM.

J Aerosol Med Pulm Drug Deliv. 2018 May 23. doi: 10.1089/jamp.2017.1376. [Epub ahead of print]

PMID:
29791260
16.

Breath volatile organic compounds of lung transplant recipients with and without chronic lung allograft dysfunction.

Küppers L, Holz O, Schuchardt S, Gottlieb J, Fuge J, Greer M, Hohlfeld JM.

J Breath Res. 2018 Jun 20;12(3):036023. doi: 10.1088/1752-7163/aac5af.

PMID:
29771243
17.

Airway and systemic inflammatory responses to ultrafine carbon black particles and ozone in older healthy subjects.

Holz O, Heusser K, Müller M, Windt H, Schwarz K, Schindler C, Tank J, Hohlfeld JM, Jordan J.

J Toxicol Environ Health A. 2018;81(13):576-588. doi: 10.1080/15287394.2018.1463331. Epub 2018 Apr 25.

PMID:
29693510
18.

A GATA3-specific DNAzyme attenuates sputum eosinophilia in eosinophilic COPD patients: a feasibility randomized clinical trial.

Greulich T, Hohlfeld JM, Neuser P, Lueer K, Klemmer A, Schade-Brittinger C, Harnisch S, Garn H, Renz H, Homburg U, Renz J, Kirsten A, Pedersen F, Müller M, Vogelmeier CF, Watz H.

Respir Res. 2018 Apr 4;19(1):55. doi: 10.1186/s12931-018-0751-x.

19.

Phase 1 pharmacokinetics and phase 3 efficacy of testosterone nasal gel in subjects with seasonal allergies.

Rogol AD, Tkachenko N, Badorrek P, Hohlfeld JM, Bryson N.

Can Urol Assoc J. 2018 Jul;12(7):E349-E356. doi: 10.5489/cuaj.4898. Epub 2018 Mar 19.

20.

ATTACHMENT IN INFANTS WITH CLEFT LIP AND/OR PALATE: MARGINAL SECURITY AND ITS CHANGES OVER TIME.

Borghini A, Despars J, Habersaat S, Turpin H, Monnier M, Ansermet F, Hohlfeld J, Muller-Nix C.

Infant Ment Health J. 2018 Mar;39(2):242-253. doi: 10.1002/imhj.21696. Epub 2018 Feb 28.

PMID:
29489020
21.

Effect of lung deflation with indacaterol plus glycopyrronium on ventricular filling in patients with hyperinflation and COPD (CLAIM): a double-blind, randomised, crossover, placebo-controlled, single-centre trial.

Hohlfeld JM, Vogel-Claussen J, Biller H, Berliner D, Berschneider K, Tillmann HC, Hiltl S, Bauersachs J, Welte T.

Lancet Respir Med. 2018 May;6(5):368-378. doi: 10.1016/S2213-2600(18)30054-7. Epub 2018 Feb 21.

PMID:
29477448
22.

International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis.

Wise SK, Lin SY, Toskala E, Orlandi RR, Akdis CA, Alt JA, Azar A, Baroody FM, Bachert C, Canonica GW, Chacko T, Cingi C, Ciprandi G, Corey J, Cox LS, Creticos PS, Custovic A, Damask C, DeConde A, DelGaudio JM, Ebert CS, Eloy JA, Flanagan CE, Fokkens WJ, Franzese C, Gosepath J, Halderman A, Hamilton RG, Hoffman HJ, Hohlfeld JM, Houser SM, Hwang PH, Incorvaia C, Jarvis D, Khalid AN, Kilpeläinen M, Kingdom TT, Krouse H, Larenas-Linnemann D, Laury AM, Lee SE, Levy JM, Luong AU, Marple BF, McCoul ED, McMains KC, Melén E, Mims JW, Moscato G, Mullol J, Nelson HS, Patadia M, Pawankar R, Pfaar O, Platt MP, Reisacher W, Rondón C, Rudmik L, Ryan M, Sastre J, Schlosser RJ, Settipane RA, Sharma HP, Sheikh A, Smith TL, Tantilipikorn P, Tversky JR, Veling MC, Wang Y, Westman M, Wickman M, Zacharek M.

Int Forum Allergy Rhinol. 2018 Feb;8(2):108-352. doi: 10.1002/alr.22073.

23.

Comparison of quantitative regional ventilation-weighted fourier decomposition MRI with dynamic fluorinated gas washout MRI and lung function testing in COPD patients.

Kaireit TF, Gutberlet M, Voskrebenzev A, Freise J, Welte T, Hohlfeld JM, Wacker F, Vogel-Claussen J.

J Magn Reson Imaging. 2018 Jun;47(6):1534-1541. doi: 10.1002/jmri.25902. Epub 2017 Nov 21.

PMID:
29160020
24.

Free-breathing Dynamic 19F Gas MR Imaging for Mapping of Regional Lung Ventilation in Patients with COPD.

Gutberlet M, Kaireit TF, Voskrebenzev A, Lasch F, Freise J, Welte T, Wacker F, Hohlfeld JM, Vogel-Claussen J.

Radiology. 2018 Mar;286(3):1040-1051. doi: 10.1148/radiol.2017170591. Epub 2017 Oct 3.

PMID:
28972817
25.

Influence of lung CT changes in chronic obstructive pulmonary disease (COPD) on the human lung microbiome.

Engel M, Endesfelder D, Schloter-Hai B, Kublik S, Granitsiotis MS, Boschetto P, Stendardo M, Barta I, Dome B, Deleuze JF, Boland A, Müller-Quernheim J, Prasse A, Welte T, Hohlfeld J, Subramanian D, Parr D, Gut IG, Greulich T, Koczulla AR, Nowinski A, Gorecka D, Singh D, Gupta S, Brightling CE, Hoffmann H, Frankenberger M, Hofer TP, Burggraf D, Heiss-Neumann M, Ziegler-Heitbrock L, Schloter M, Zu Castell W.

PLoS One. 2017 Jul 13;12(7):e0180859. doi: 10.1371/journal.pone.0180859. eCollection 2017.

26.

Dose-response relationship of a new Timothy grass pollen allergoid in comparison with a 6-grass pollen allergoid.

Pfaar O, Hohlfeld JM, Al-Kadah B, Hauswald B, Homey B, Hunzelmann N, Schliemann S, Velling P, Worm M, Klimek L.

Clin Exp Allergy. 2017 Nov;47(11):1445-1455. doi: 10.1111/cea.12977. Epub 2017 Oct 16.

PMID:
28696503
27.

A European Respiratory Society technical standard: exhaled biomarkers in lung disease.

Horváth I, Barnes PJ, Loukides S, Sterk PJ, Högman M, Olin AC, Amann A, Antus B, Baraldi E, Bikov A, Boots AW, Bos LD, Brinkman P, Bucca C, Carpagnano GE, Corradi M, Cristescu S, de Jongste JC, Dinh-Xuan AT, Dompeling E, Fens N, Fowler S, Hohlfeld JM, Holz O, Jöbsis Q, Van De Kant K, Knobel HH, Kostikas K, Lehtimäki L, Lundberg J, Montuschi P, Van Muylem A, Pennazza G, Reinhold P, Ricciardolo FLM, Rosias P, Santonico M, van der Schee MP, van Schooten FJ, Spanevello A, Tonia T, Vink TJ.

Eur Respir J. 2017 Apr 26;49(4). pii: 1600965. doi: 10.1183/13993003.00965-2016. Print 2017 Apr.

28.

Blood eosinophils predict therapeutic effects of a GATA3-specific DNAzyme in asthma patients.

Krug N, Hohlfeld JM, Buhl R, Renz J, Garn H, Renz H.

J Allergy Clin Immunol. 2017 Aug;140(2):625-628.e5. doi: 10.1016/j.jaci.2017.02.024. Epub 2017 Mar 22. No abstract available.

PMID:
28342914
29.

Specificity and reproducibility of nasal biomarkers in patients with allergic rhinitis after allergen challenge chamber exposure.

Badorrek P, Müller M, Koch W, Hohlfeld JM, Krug N.

Ann Allergy Asthma Immunol. 2017 Mar;118(3):290-297. doi: 10.1016/j.anai.2017.01.018.

30.

Allergen exposure chambers: harmonizing current concepts and projecting the needs for the future - an EAACI Position Paper.

Pfaar O, Calderon MA, Andrews CP, Angjeli E, Bergmann KC, Bønløkke JH, de Blay F, Devillier P, Ellis AK, Gerth van Wijk R, Hohlfeld JM, Horak F, Jacobs RL, Jacobsen L, Jutel M, Kaul S, Larché M, Larenas-Linnemann D, Mösges R, Nolte H, Patel P, Peoples L, Rabin RL, Rather C, Salapatek AM, Sigsgaard T, Thaarup S, Yang J, Zieglmayer P, Zuberbier T, Demoly P.

Allergy. 2017 Jul;72(7):1035-1042. doi: 10.1111/all.13133. Epub 2017 May 4. Review.

PMID:
28122133
31.

Severe asthma exists despite suppressed tissue inflammation: findings of the U-BIOPRED study.

Wilson SJ, Ward JA, Sousa AR, Corfield J, Bansal AT, De Meulder B, Lefaudeux D, Auffray C, Loza MJ, Baribaud F, Fitch N, Sterk PJ, Chung KF, Gibeon D, Sun K, Guo YK, Adcock I, Djukanovic R, Dahlen B, Chanez P, Shaw D, Krug N, Hohlfeld J, Sandström T, Howarth PH; U-BIOPRED Study Group.

Eur Respir J. 2016 Nov;48(5):1307-1319. doi: 10.1183/13993003.01129-2016. Epub 2016 Oct 6.

32.

Safety, efficacy and repeatability of a novel house dust mite allergen challenge technique in the Fraunhofer allergen challenge chamber.

Lueer K, Biller H, Casper A, Windt H, Mueller M, Badorrek P, Haefner D, Framke T, Koch A, Ziehr H, Krug N, Koch W, Hohlfeld JM.

Allergy. 2016 Dec;71(12):1693-1700. doi: 10.1111/all.12947. Epub 2016 Jun 23.

PMID:
27255590
33.

Emphysema- and airway-dominant COPD phenotypes defined by standardised quantitative computed tomography.

Subramanian DR, Gupta S, Burggraf D, Vom Silberberg SJ, Heimbeck I, Heiss-Neumann MS, Haeussinger K, Newby C, Hargadon B, Raj V, Singh D, Kolsum U, Hofer TP, Al-Shair K, Luetzen N, Prasse A, Müller-Quernheim J, Benea G, Leprotti S, Boschetto P, Gorecka D, Nowinski A, Oniszh K, Castell WZ, Hagen M, Barta I, Döme B, Strausz J, Greulich T, Vogelmeier C, Koczulla AR, Gut I, Hohlfeld J, Welte T, Lavae-Mokhtari M, Ziegler-Heitbrock L, Brightling C, Parr DG.

Eur Respir J. 2016 Jul;48(1):92-103. doi: 10.1183/13993003.01878-2015. Epub 2016 May 26.

34.

Tiotropium Respimat(®) Versus HandiHaler(®): Comparison of Bronchodilator Efficacy of Various Doses in Clinical Trials.

Calverley PM, Könen-Bergmann M, Richard F, Bell S, Hohlfeld JM.

Adv Ther. 2016 May;33(5):786-93. doi: 10.1007/s12325-016-0322-9. Epub 2016 Mar 28.

35.

A dual center study to compare breath volatile organic compounds from smokers and non-smokers with and without COPD.

Gaida A, Holz O, Nell C, Schuchardt S, Lavae-Mokhtari B, Kruse L, Boas U, Langejuergen J, Allers M, Zimmermann S, Vogelmeier C, Koczulla AR, Hohlfeld JM.

J Breath Res. 2016 Apr 15;10(2):026006. doi: 10.1088/1752-7155/10/2/026006.

PMID:
27082437
36.

Measurement of exhaled volatile organic compounds from patients with chronic obstructive pulmonary disease (COPD) using closed gas loop GC-IMS and GC-APCI-MS.

Allers M, Langejuergen J, Gaida A, Holz O, Schuchardt S, Hohlfeld JM, Zimmermann S.

J Breath Res. 2016 Apr 8;10(2):026004. doi: 10.1088/1752-7155/10/2/026004.

PMID:
27058460
37.

Inter- and intrasubject variability of the inflammatory response to segmental endotoxin challenge in healthy volunteers.

Holz O, Tan L, Schaumann F, Müller M, Scholl D, Hidi R, McLeod A, Krug N, Hohlfeld JM.

Pulm Pharmacol Ther. 2015 Dec;35:50-9. doi: 10.1016/j.pupt.2015.10.011. Epub 2015 Nov 10.

38.

Grommets and speech at three and six years in children born with total cleft or cleft palate.

Ezzi OE, Herzog G, Broome M, Trichet-Zbinden C, Hohlfeld J, Cherpillod J, de Buys Roessingh AS.

Int J Pediatr Otorhinolaryngol. 2015 Dec;79(12):2243-7. doi: 10.1016/j.ijporl.2015.10.012. Epub 2015 Oct 20.

PMID:
26545794
39.

Efficacy and safety of a novel nasal steroid, S0597, in patients with seasonal allergic rhinitis.

Badorrek P, Hohlfeld JM, Krug N, Joshi A, Raut A.

Ann Allergy Asthma Immunol. 2015 Oct;115(4):325-329.e1. doi: 10.1016/j.anai.2015.07.016. Epub 2015 Aug 11.

40.

Efficacy and safety of inhaled calcium lactate PUR118 in the ozone challenge model--a clinical trial.

Holz O, Biller H, Mueller M, Kane K, Rosano M, Hanrahan J, Hava DL, Hohlfeld JM.

BMC Pharmacol Toxicol. 2015 Aug 12;16:21. doi: 10.1186/s40360-015-0021-1.

41.

Constant-load exercise decreases the serum concentration of myeloperoxidase in healthy smokers and smokers with COPD.

Holz O, Roepcke S, Watz H, Tegtbur U, Lahu G, Hohlfeld JM.

Int J Chron Obstruct Pulmon Dis. 2015 Jul 21;10:1393-402. doi: 10.2147/COPD.S83269. eCollection 2015.

42.

Exacerbation of atopic dermatitis on grass pollen exposure in an environmental challenge chamber.

Werfel T, Heratizadeh A, Niebuhr M, Kapp A, Roesner LM, Karch A, Erpenbeck VJ, Lösche C, Jung T, Krug N, Badorrek P, Hohlfeld JM.

J Allergy Clin Immunol. 2015 Jul;136(1):96-103.e9. doi: 10.1016/j.jaci.2015.04.015. Epub 2015 Jun 1.

PMID:
26044854
43.

Childhood asthma is associated with mutations and gene expression differences of ORMDL genes that can interact.

Toncheva AA, Potaczek DP, Schedel M, Gersting SW, Michel S, Krajnov N, Gaertner VD, Klingbeil JM, Illig T, Franke A, Winkler C, Hohlfeld JM, Vogelberg C, von Berg A, Bufe A, Heinzmann A, Laub O, Rietschel E, Simma B, Genuneit J, Muntau AC, Kabesch M.

Allergy. 2015 Oct;70(10):1288-99. doi: 10.1111/all.12652. Epub 2015 Jul 20.

PMID:
26011647
44.

Allergen-induced asthmatic responses modified by a GATA3-specific DNAzyme.

Krug N, Hohlfeld JM, Kirsten AM, Kornmann O, Beeh KM, Kappeler D, Korn S, Ignatenko S, Timmer W, Rogon C, Zeitvogel J, Zhang N, Bille J, Homburg U, Turowska A, Bachert C, Werfel T, Buhl R, Renz J, Garn H, Renz H.

N Engl J Med. 2015 May 21;372(21):1987-95. doi: 10.1056/NEJMoa1411776. Epub 2015 May 17.

45.

[Vascular anomalies].

Krieger Caroline, Roessingh Ade B, Depairon M, El Ezzi O, Hohlfeld J, Raffoul W, Qanadli SD, Mazzolai L.

Rev Med Suisse. 2015 Feb 4;11(460):357-61. French.

PMID:
25854046
46.

Safety and tolerability of a novel inhaled GATA3 mRNA targeting DNAzyme in patients with TH2-driven asthma.

Homburg U, Renz H, Timmer W, Hohlfeld JM, Seitz F, Lüer K, Mayer A, Wacker A, Schmidt O, Kuhlmann J, Turowska A, Roller J, Kutz K, Schlüter G, Krug N, Garn H.

J Allergy Clin Immunol. 2015 Sep;136(3):797-800. doi: 10.1016/j.jaci.2015.02.018. Epub 2015 Apr 2. No abstract available.

PMID:
25842286
47.

Cardiac safety of tiotropium in patients with COPD: a combined analysis of Holter-ECG data from four randomised clinical trials.

Hohlfeld JM, Furtwaengler A, Könen-Bergmann M, Wallenstein G, Walter B, Bateman ED.

Int J Clin Pract. 2015 Jan;69(1):72-80. doi: 10.1111/ijcp.12596. Epub 2014 Dec 11.

48.

Rhinopharyngeal autologous fat injection for treatment of velopharyngeal insufficiency in patients with cleft palate.

Piotet E, Beguin C, Broome M, Iglesias K, Olivier F, Leuchter I, Zbinden C, Hohlfeld J, de Buys Roessingh A, Schweizer V, Pasche P.

Eur Arch Otorhinolaryngol. 2015 May;272(5):1277-85. doi: 10.1007/s00405-014-3380-0. Epub 2014 Nov 20.

PMID:
25411074
49.

Effects of ultrafine particles on the allergic inflammation in the lung of asthmatics: results of a double-blinded randomized cross-over clinical pilot study.

Schaumann F, Frömke C, Dijkstra D, Alessandrini F, Windt H, Karg E, Müller M, Winkler C, Braun A, Koch A, Hohlfeld JM, Behrendt H, Schmid O, Koch W, Schulz H, Krug N.

Part Fibre Toxicol. 2014 Sep 10;11:39. doi: 10.1186/s12989-014-0039-3.

50.

Noninvasive quantification of airway inflammation following segmental allergen challenge with functional MR imaging: a proof of concept study.

Renne J, Hinrichs J, Schönfeld C, Gutberlet M, Winkler C, Faulenbach C, Jakob P, Schaumann F, Krug N, Wacker F, Hohlfeld JM, Vogel-Claussen J.

Radiology. 2015 Jan;274(1):267-75. doi: 10.1148/radiol.14132607. Epub 2014 Sep 8.

PMID:
25203130

Supplemental Content

Loading ...
Support Center